iBio 12-month price target raised to $5.6
An analyst raised iBio’s 12-month price target to $5.6, implying 509% upside.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.